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Longitudinal modelling of theory-based depressive vulnerabilities, depression trajectories and 
poor outcomes post-ACS 
 
Background: Depression is associated with increased mortality in patients with acute coronary syn-
drome (ACS). However, little is known about the theoretical causes of depression trajectories post-
ACS, and whether these trajectories predict subsequent morbidity/mortality. We tested a longitudi-
nal model of depressive vulnerabilities, trajectories and mortality. 
Methods: A prospective observational study of 374 ACS patients was conducted. Participants com-
pleted questionnaires on theoretical vulnerabilities (interpersonal life events, reinforcing events, 
cognitive distortions, Type D personality) during hospitalisation and depression at baseline and 3, 6 
and 12 months post-hospitalisation. Latent class analysis determined trajectories of depression. Path 
analysis was used to test relationships among vulnerabilities, depression trajectories and outcomes 
(combination of 1-year morbidity and 7-year mortality). 
Results:  Vulnerabilities independently predicted persistent and subthreshold depression trajectory 
categories, with effect sizes significantly highest for persistent depression. Both subthreshold and 
persistent depression trajectories were significant predictors of morbidity/mortality (e.g. persistent 
depression OR=2.4, 95% CI=1.8-3.1, relative to never depressed). 
Limitations: Causality cannot be inferred from these associations. We had no measures of history of 
depression or treatments, which may affect associations. 
Conclusions: Theoretical vulnerabilities predicted depression trajectories, which in turn predicted 
increased morbidity/mortality, demonstrating for the first time a potential longitudinal chain of 
events post-ACS. This longitudinal model has important practical implications as clinicians can use 
vulnerability measures to identify those at most risk of poor outcomes.  
 
 
  
  
Highlights 
- We tested a longitudinal model of theoretical vulnerabilities, depression trajectories and 
mortality  
- Vulnerability measures predicted subthreshold and persistent depression trajectories 
- Both depressive symptom trajectories predicted morbidity/mortality 
- Clinicians can use vulnerability measures to identify patients at higher risk of poor prognosis 
 
 
Keywords: Depression, Coronary heart disease, Psychological theory, Depressive vulnerabilities, De-
pressive trajectories.  
 
Abbreviations:  
ACS: Acute coronary syndrome 
BDI-FS: Beck Depression Inventory – Fast Screen 
BJW-S: Belief in Just World-Self scale 
DS14: Type D Scale 
ENRICHD: Enhancing recovery in coronary heart disease patients randomised trial 
GSEM: Generalised Structural Equation Model 
HADS-D: Hospital Anxiety and Depression Scale depression subscale 
LTE-Q: List of threatening Experiences Questionnaire 
MI: myocardial infarction 
PES-AD: Pleasant Events Schedule – Alzheimer’s Disease (short version) 
 
  
  
Introduction 
Acute coronary syndrome (ACS) comprises myocardial infarction (MI) and unstable angina (Hamm et 
al., 2011). A large literature has investigated the association between ACS, or mostly MI, and depres-
sive symptoms. In general, the literature shows that these conditions are inextricably linked in sev-
eral ways. Meta-analyses have shown not only elevated levels of depressive symptoms post-ACS, but 
also that these symptoms are associated with poorer prognosis (Doyle et al., 2015; Meijer et al., 
2011). A more recent individual patient data meta-analysis of 10,175 post-MI patients showed that 
depressive symptoms led to an increased risk of mortality 32% per standard deviation increase in 
depressive symptoms, when adjusting for age and sex (Meijer et al., 2013a). Although full adjust-
ment of cardiovascular disease indices and risk factors was not possible, due to the heterogeneity of 
the combined studies, the results were consistent after adjustment. Those with elevated depressive 
symptoms had 25-34% increased risk of deaths per standard deviation increase in depressive symp-
toms. However, despite the fact that depressive symptoms seem to confer increased mortality risk, 
the treatment of depression has failed to show any alleviation of risk (The ENRICHD Investigators, 
2003; van Melle et al., 2007), thereby calling into question whether depression can truly be seen as a 
risk factor for MI, or is better seen as a risk marker (Freedland and Carney, 2013; Meijer et al., 
2013b). 
 
There are undoubtedly weaknesses in this literature. Previous research has shown a relationship 
between disease severity, in particular left ventricular ejection function (LVEF), and depressive 
symptoms (Delisle et al., 2012; Nicholson et al., 2006; van Melle et al., 2005), which is obviously a 
potential confounder in the depression-prognosis link.  Another aspect of the relationship between 
depression and prognosis relates to the course depression may take following discharge. While the 
prevalence of depression remains fairly stable over time, its trajectory may not (Kaptein et al., 2006; 
Martens et al., 2008). For example, trajectories of non-depressed, mildly depressed, moderately de-
pressed and severely depressed were found when measuring depressive symptoms post-MI, and 
  
two and 12 months later in 287 patients (Martens et al., 2008). In a larger sample of 475 patients 
post-MI a different evolution of depressive symptoms in up to 5 groups (Kaptein et al., 2006). These 
divided into those with no depressive symptoms, mild depressive symptoms, moderate and increas-
ing depressive symptoms, significant but decreasing depressive symptoms and significant and in-
creasing depressive symptoms. Furthermore, those with significant and increasing depressive symp-
toms were at higher risk of further cardiovascular events up to 2.5 years later, when compared to 
those with no depressive symptoms.  
 
While it is obviously important to map different trajectories of depression, it would be especially 
useful for clinicians to be able to identify those who are at risk of elevated depressive symptoms 
over time, in order to choose appropriate treatment options. However, relatively little work has 
been conducted in this area, and the work that has been done has been largely atheoretical – mean-
ing that it provides little in the way of usable information for intervention design. Theoretical vul-
nerabilities to depression, such as stressful life events, distorted cognitions, low levels of positive 
reinforcement and personality traits, have been shown to predict depressive symptoms in cross-
sectional and prospective studies, and indeed are better predictors of depression than disease and 
sociodemographic indices (Doyle et al., 2011a; Doyle et al., 2011b; Rieckmann et al., 2006). These 
results highlighted the complexity of the aetiology of depressive symptoms in this population – 
which mirrors the aetiology in depressed patients without co-morbid physical disease.  
 
Current findings therefore suggest a relationship between vulnerabilities and depressive trajectories 
and also, separately, a relationship between depression and prognosis. No analysis has yet taken 
place to understand these relationships in a structural context.  This paper draws on our previous 
reports in order to test a parsimonious model of theoretically-informed depressive vulnerabilities, 
depression trajectories and poor outcomes in patients with ACS. Identifying such a longitudinal chain 
relationship may aid early identification of patients at significant risk of adverse clinical outcomes. In 
  
the current study, we conducted a path analysis to elucidate the interrelationships between these 
theoretically-informed depression vulnerabilities, depressive trajectories and subsequent morbidi-
ty/mortality. Path analysis is an extension of regression analysis that estimates a system of equa-
tions which allows researchers to empirically test all structural linkages, both direct and mediating, 
that are theorised to exist among variables (Kline, 2011; Lleras, 2005).  A major advantage of path 
analysis is that through estimating all associations proposed by theory, it allows researchers to em-
pirically disentangle complex relationships. Addressing such interrelationships in simple linear mod-
els is likely to lead to erroneous conclusions (Christenfeld et al., 2004; Kraemer et al., 2001). We hy-
pothesised significant associations among theoretical vulnerabilities, depression trajectories and 
poor clinical outcomes. 
 
 
Methods 
Study design and participants 
A clinical cohort design was used. The baseline sample, depressive trajectories and 1-year mortality 
have been previously reported (Doyle et al., 2010; Doyle et al., 2011a; Doyle et al., 2011b). Following 
ethical approval, consecutive patients with confirmed ACS from 12 hospitals who were literate in 
English were recruited by coronary care staff to participate in the survey during their hospital stay. 
While in hospital patients completed a composite psychological questionnaire, and demographic 
(age, sex, marital, insurance and employment status) and cardiovascular disease risk factors (e.g. 
smoking, prior coronary heart disease or revascularisation, diabetes, cholesterol, hypertension) and 
treatments or status during hospitalisation (revascularisation, length of stay, left ventricular func-
tion, cardiac arrest) were recorded. The Charlson Co-morbidity Index (CCI) was also used to account 
for major co-morbidities, but a modified score (omitting separately assessed comorbidities, i.e. MI, 
diabetes) was used. Patient charts were accessed 12 month post-hospitalisation to obtain data on 
recurrent hospitalisation and morbidity. Patients were also followed up by postal survey, containing 
  
measures of depression, at 3-, 6- and 12-months directly post-hospitalisation (see Appendix A). At 7-
years, all-cause mortality data was obtained from the General Registry Office of Births, Deaths and 
Marriages. 
 
Depression assessment and trajectories 
Beck Depression Inventory – Fast Screen (BDI-FS) 
The BDI-FS is a 7-item self-completion depression screen that focuses on cognitive symptoms of de-
pression, and omits somatic items, and the >3 threshold has been shown to have a sensitivity and 
specificity of >.85 when identifying major depression (Scheinthal et al., 2001).  We used 6 of the 
items only, omitting suicidality due to its apparent negative impact on patient response rates 
(McGee et al., 2006).  
 
Hospital Anxiety and Depression Scale depression subscale) (HADS-D) 
The HADS-D is a popular 7-item depression subscale, which is scored with a 4-answer option format, 
that focuses mainly on anhedonic symptoms (Zigmond and Snaith, 1983). A score of >7 is yields sen-
sitivity and specificity of .82 and .74 respectively for identifying major depression (Brennan et al., 
2010).  
 
Trajectories 
Both the BDI-FS and the HADS-D continuous scores were used to develop depression trajectory cat-
egories, using the SAS PROC TRAJ latent class analysis command as outlined in detail elsewhere 
(Doyle et al., 2011b). In summary, a dual/joint trajectory model for both depression scales was fit-
ted. The dual model jointly estimates the trajectories of two distinct but related longitudinal out-
comes.  Initially the appropriate number of groups and orders for the two single censored normal 
trajectory models were established, using change in Bayesian Information Criterion to decide on the 
optimum number of groups, with group orders set to the second order. Following group selection, 
  
the shape of the pattern of change over time was determined using a cubic trajectory model initially, 
decreasing the order for each group so that the highest order parameter estimates were significant. 
Having established the appropriate number of groups and orders, a joint trajectory model was fitted. 
Missing data was modelled as missing at random, allowing each participant to be grouped into a tra-
jectory. All follow-up depression measures were completed by 250 participants, with the remaining 
missing at least one follow-up depression measure. Non-responders were less likely to have private 
health insurance or have a partner (data not shown), but no other differences were found (Doyle et 
al, 2011b). This analysis found the following depressive symptom trajectories: never depressed 
(48%), subthreshold (i.e. scores above zero but below to the recommended scale cut-points, 37%) 
and persistent (i.e. persistently elevated above recommended scale thresholds, 15%).   
 
 
Theoretical Vulnerabilities 
List of threatening Experiences Questionnaire 
The List of Threatening Experiences Questionnaire (LTE-Q) was used to assess the extent of interper-
sonal and life event difficulties that patients may have experienced in the year prior to their hospital 
admission. The LTE-Q is a 12-item schedule which assesses stressful life events (Brugha and Cragg, 
1990). The authors showed that the LTE-Q had high test–retest reliability and compared well with an 
interview technique (sensitivity/specificity ranges for stressful life events were between 0.89 and 
1.0/ between 0.74 and 0.88, respectively), in psychiatric patients. Examples of life events on the LTE-
Q are experiencing a serious illness or assault, or a relationship breakup. 
 
Belief in Just World-Self scale 
Belief in a Just World–Self scale (BJW) refers to the belief that good things happen to good people 
and bad things happen to bad people, and a ‘distorted’ BJW (i.e., non-belief in a just world) has been 
  
associated with depression (Furnham, 2003; Lipkus et al., 1996). The eight-item BJW-S scale (α=.81) 
was used to assess just world beliefs pertaining to onself (Lipkus et al., 1996). 
 
Pleasant Events Schedule – Alzheimer’s Disease (short version) 
Pleasant events were assessed using this schedule, originally developed for persons with Alzheimer's 
disease, but a variant has been used in ACS patients (Logsdon and Teri, 1997; Rieckmann et al., 
2006). It is a 20-item behavioural log that rates the frequency and enjoyment of pleasant behav-
iours/events in the past month. As in previous research, missing items were coded as 0 if at least 
half of the 20 items had been answered (Rieckmann et al., 2006). A cross-product produced a total 
schedule score of positive reinforcement in the past month. As the PES-AD is a schedule reliability 
statistics are inappropriate. 
 
Type D Scale – DS14 
This 14-item scale measures whether or not participants have a distressed (Type D) personality – a 
composition of the disposition towards social inhibition and negative affectivity, which was originally 
developed in cardiac patients (Denollet, 2005). Recent work with the DS14 scale suggests that it is 
best considered as an interaction between the subscales – and we adopted this method here 
(Ferguson et al., 2009).  
 
Comparing vulnerabilities 
For comparability the scores of the vulnerability scales were recoded to indicate a higher theoretical 
risk for depression (i.e., a lack of positive reinforcement, not believing in a just world, but higher 
numbers of stressful life events and higher levels of Type D personality). For effect size comparabil-
ity, scale scores were standardized, with effect sizes representing a 1-standard deviation (SD) in-
crease in vulnerability. 
 
  
Outcome Event 
We assessed unplanned hospital readmission including for non-fatal MI, stroke or non-cardiac re-
admissions and 7-year all-cause mortality. For the primary analyses we combined the above events 
into a binary variable in order to maximise power, as the majority of events occurred within 12-
months of baseline assessment. We also considered all-cause mortality after 12-months separately. 
 
Statistical Analysis 
Logistic regression assessed the association among demographic factors, cardiovascular risk and dis-
ease indices, theoretical vulnerabilities, depression trajectories and outcomes. Statistical analysis 
was conducted using a path model.  As described above, path analysis allows the specification and 
testing of structural models that reflect assumptions about the direction of associations that exist 
among variables. Figures 1a and 1b outlined the two path models specified. The first tested the as-
sociations among vulnerabilities, depression trajectories and morbidity/mortality. The second also 
controlled for the impact of pertinent sociodemographic and disease indices which predicted the 
endpoint in the current sample. As depression is among the most consistent predictors of morbidi-
ty/mortality post-ACS, we expected depressive trajectories to mediate the association among the 
vulnerabilities and endpoints.   Baseline depression scores were already included in depression tra-
jectories and consequently no relationship was specified between baseline depression and trajecto-
ries in these models. The dependent variables in our models were depressive trajectories, baseline 
depression and poor outcome. The former was predicted by means of a multinomial logit model 
(with never depressed as a reference category) with the latter two predicted by means of binary 
logit model. Coefficients were reported in terms of odds ratios. Akaike and Bayesian) Information 
Criteria scores were calculated to compare relative model fit. Path analysis was conducted using 
Stata 13.0 Generalised Structural Equation Model (GSEM) estimation command. Choice of risk fac-
tors to include in the expanded path analysis was determined through a multivariate logistic regres-
sion analysis of significant demographic and disease predictors of outcome. Sex and left ventricular 
  
function were added to model two as recent findings indicated these are important determinants of 
depression and sex differences in prognosis post-MI (Doyle et al., 2015). To avoid overfitting, further 
adjustments were not made. All statistical analysis was accounted for clustering of patients at the 
hospital level, using adjusted standard errors and robust variance estimation using the Huber–White 
method. We also considered further sensitivity analyses, where we compared the models using 
post-12-month all-cause mortality only, and 1-year morbidity/mortality only.  
 
Fig 1 about here 
 
Results 
Of the original 430 ACS patients recruited, 374 are included in the current analysis (87%). These in-
cluded those who completed at least one follow-up survey measure. Descriptive statistics are re-
ported in Table 1. Overall, 38% (141/374) of our sample experienced an outcome event, with 31% 
(115/374) happening within the first 12 months. In terms of socio-demographic variables, those who 
experienced the outcome event were likely to be older and not in employment. Prior hypertension, 
total cholesterol, prior coronary heart disease and prior revascularisation, length of stay and LVEF < 
40% were all also associated with outcome.  While depressive vulnerabilities were not associated 
with outcome, depressive trajectories were. 
Table 1 about here 
 
Table 2 reports the results of a multivariate logistic regression to determine which factors inde-
pendently associated with the outcome event. Results indicate that age, prior coronary disease and 
length of hospital stay were all independent predictors of outcome. These variables were then in-
cluded as risk factors for prognosis in the path analysis, along with LVEF (see Table 4).  
Table 2 about here 
 
  
Table 3 reports the results of the first path analysis model specified (excluding potentially confound-
ing risk factors – also see Appendix B1 for co-efficients). All vulnerabilities were positively predictive 
of baseline depression. Relative to never depressed, all vulnerabilities were also positively predictive 
of persistent depression. All vulnerabilities, apart from Type D personality were also predictive of 
subthreshold depression. Larger effect sizes were observable for persistent depression.  In turn, de-
pressive trajectories were also predictive of the outcome event. Relative to never depressed, those 
with subthreshold depression had 38% higher risk of experiencing the outcome. Furthermore, expe-
riencing morbidity/mortality was 2.4 times more likely in the persistent depression group relative to 
the never depressed group. 
Table 3 about here 
 
Results for the second model which included potential confounding risk factors are reported in Table 
4 (also see Appendix B2 for co-efficients). Age, prior coronary heart disease, and length of stay were 
all positive and significant predictors of the outcome event, however, they did not materially affect 
the impact of either subthreshold or persistent depression on outcomes. Notably, including sex as a 
predictor of depressive trajectories indicated that low reinforcement were no longer significant pre-
dictors of subthreshold depression (relative to never depressed), although sex itself was not a statis-
tically significant predictor of depression trajectories. Both AIC and BIC scores were lower for the 
second model, indicating relatively better model fit. Sensitivity analyses had little effect on the effect 
sizes for the association between trajectories and outcomes, but statistical significance was lost due 
to the small number of events when predicting one-year outcomes (Appendix C). 
Tale 4 about here 
 
Discussion 
Previous research has reported links between theoretical vulnerabilities and depression trajectories 
and also between depressive trajectories and poor outcome in patients with acute coronary syn-
  
drome. This paper proposed to advance current understanding by, for the first time to our 
knowledge, testing a theoretical model that proposes an explanatory relationship between these 
processes. We showed that theoretical vulnerabilities predicted depressive symptom trajectories, 
which in turn predicted morbidity/mortality. Importantly, these relationships were not affected by 
important demographic or disease indices. While previous research has demonstrated the im-
portance of these vulnerabilities for depression and depression trajectories, that these are ultimate-
ly interlinked illustrates a potential longitudinal and structural chain of events.  
 
Low reinforcement, non-belief in a just world, stressful life events and Type D personality significant-
ly influenced not only baseline depression but also the trajectory depression took following dis-
charge from hospital. Vulnerabilities were all independent predictors of the trajectories, probably 
indicating the heterogeneous aetiology of depression and their associated theories. As noted, the 
relationship between theoretical vulnerabilities, depressive symptoms and trajectories, and out-
comes has been examined previously (Doyle et al., 2011b; Kaptein et al., 2006; Martens et al., 2008; 
Rieckmann et al., 2006), but not all simultaneously. It is perhaps not surprising that depressive tra-
jectories were strongly predictive of outcome, given the well-established association between de-
pression and mortality in coronary patients (Meijer et al., 2013a). However, what is new in this study 
is the fact that both depression trajectories – subthreshold and persistent – were associated with 
increased risk of poorer outcomes. While previously it has been shown that even subclinical depres-
sive symptoms can lead to increased cardiovascular risk (Bush et al., 2001), the current findings sup-
port this by showing a roughly 40% increased risk of poor outcomes for those with subthreshold de-
pression. That a subthreshold trajectory of post-ACS depressive symptoms was associated with out-
come is in contrast to other studies of depression trajectories, where outcome was associated with 
only the most severe trajectories (e.g. elevated and worsening depression) (Kaptein et al., 2006). 
However, the effects for the persistent depression group were even stronger, with an approximately 
2- to 3-fold increased risk of poor outcomes. These results highlight the importance of being able to 
  
identify those at increased risk of persistent depression, and the use of vulnerabilities, as was the 
case here, should aid clinicians to do this. The results from this study should therefore have im-
portant theoretical and practical implications.  
 
Two recent randomised trials may demonstrate how important depressive vulnerabilities are for 
care. The recent CODIACS trial showed that stepped care for those with elevated depressive symp-
toms post-ACS was effective for reducing depressive symptoms within six months (Davidson et al., 
2013) – indeed the results showed stronger effects than other randomised trials. Patients were ran-
domised to 6 months of depression care treatment according to their preference – problem-solving 
therapy (telephone or interactive internet video-based), pharmacotherapy or a combination of both. 
The COPES trial of post-ACS depressive symptom treatment had similar findings with unusually large 
effects – an intervention group who reported preferences for pharmacotherapy or psychotherapy 
had higher satisfaction with depression care and lower depressive symptoms in comparison to a 
usual care group (Davidson et al., 2010). The authors also reported a trend towards lower subse-
quent cardiovascular morbidity rates in the intervention group, albeit the study was not powered to 
detect such differences. It is probable that patient preferences for each type of treatment contribut-
ed to such positive findings. However, these trials could be criticised for only providing one form of 
psychotherapy, as it is possible that other forms of psychotherapy may better suit an individual’s 
own particular vulnerability factors. For example, perhaps those experiencing stressful life events 
would prefer therapies focused on such events, such as interpersonal psychotherapy, whereas those 
with distorted cognitions would prefer cognitive therapies, etc. (Davidson et al., 2004). Patient pref-
erences for care are an important facet of retention in, and satisfaction with, psychotherapies 
(Iacoviello et al., 2007; Lin et al., 2005).  Future research should address whether depressive vulner-
abilities, similar to those assessed in this and previous studies, do in fact correlate with treatment 
preferences.  
 
  
Some apparent inconsistencies in our data deserve further comment. The finding that pertinent car-
diovascular disease indices such as LVEF did not mediate the depression-prognosis link fits with 
some recent findings (Meijer et al., 2013a) which show only partial mediation of the depression-
prognosis link when analysing various disease indices. The lack of mediation here may be explained 
by the depression scales used in the present study, which omitted somatic items, and these items 
may be more related to disease indices than other items (de Miranda Azevedo et al., 2014). It is sur-
prising that sex was not a significant predictor of depression trajectories, in contrast to current liter-
ature (Doyle et al., 2015). Again, however, it is possible that scales used may account for these find-
ings. In the COPES trial, analysis showed that women’s depressive symptoms decreased more and 
that women preferred psychotherapy, with men preferring pharmacotherapy for depression 
(Davidson et al., 2010). Furthermore, given the recent finding that LVEF is associated with depressive 
symptoms in men only, such findings indicate that it may be important to account for sex differences 
going forward, despite the current findings. Type D personality did predict depression trajectories, 
supporting other findings (Martens et al., 2008; Romppel et al., 2012), but did not predict mortality. 
This adds to the growing literature on negative findings for Type D and prognosis (Coyne et al., 2011; 
Grande et al., 2012), and while a full discussion of potential reasons is beyond the scope of this liter-
ature, it may be due to cultural differences among countries.  
 
Limitations 
This study has a number of limitations. The reliability of the trajectories may be low, and need to be 
replicated in further studies. The omission of somatic items may be problematic, as outlined above, 
as these items may better predict mortality than other depressive symptoms (de Miranda Azevedo 
et al., 2014). To maximise power for our primary analyses, we included morbidity/mortality that oc-
curred during the year post baseline hospitalisation. However, this could have led to modelling of 
essentially cross-sectional events. Furthermore, the modelling techniques available in Stata’s GSEM 
command cannot combine time-to-event analysis, which is superior to logistic modelling, with other 
  
path analytic techniques, so we used logit modelling for the outcome. When using Cox regression to 
analyse the risk factors for the expanded model we achieved similar results in the multivariate mod-
el (data not shown). Few model-fit statistics are available for such generalised modelling procedures. 
Our sensitivity analyses indicated similar effects when post-1-year mortality only was modelled, 
however, trajectories were not statistically significantly predictive of outcome. This is likely due to 
lack of statistical power.  We had no measure of a history of depression or depression treatments, 
which is likely to be crucial for predicting depression trajectories. Recall bias may have affected the 
results and the relationship among the variables. While we measured some important vulnerabili-
ties, others may also be important. Other moderating factors such as age or sex, or even interactions 
among vulnerabilities, could also be envisaged, but our aim was to build test a parsimonious model. 
Demographic factors did not contribute much to baseline depression or trajectories, so these were 
omitted here due to lack of power and parsimony. While just world beliefs may not be a typical 
measure of cognitive distortions, it independently predict trajectories, but future research could ad-
dress other cognitive vulnerabilities also. The combined outcome was heterogeneous, which may 
have affected the results, although our sensitivity analyses, albeit underpowered, did not show this. 
Furthermore, other unmeasured and confounding factors could have influence the cohort during the 
follow-up. Additionally, the persistence or otherwise of depressive symptoms after one year is un-
known. The generalisability is limited to participants who completed at least one follow-up measure, 
and missing data could contribute to misclassifications in trajectories. We do not have measures of 
health behaviours or cardiac rehabilitation attendance during follow-up, and these may mediate the 
depression-prognosis link (Doyle et al., 2014; Whooley et al., 2008).  
 
Conclusion 
Theoretical vulnerabilities predicted depression trajectories, which in turn predicted increased mor-
bidity/mortality, demonstrating for the first time a potential longitudinal chain of events post-ACS. 
Clinicians can use vulnerability measures to determine who is at higher risk of poorer prognosis. 
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Table 1: Descriptive Statistics and predictors of all-cause morbidity/mortality 
  
Total 
(N=374) 
No 
Event 
(N=233) 
Event 
(N=141)  
OR 95% CI P-value  
Demographics       
 Age (years), mean (S.D) 61.4 
(10.5) 
60.1 
(10.4) 
63.8 
(10.3) 
1.04 1.02 – 1.05 <.001*** 
 Men 79% 78% 81% 1.18 0.86 –1.63 0.299 
 Has a partner (1=yes) 75% 75% 74% 0.97 0.58 – 1.60 0.895 
 Employed (1=yes) 18% 22% 11% 0.45 0.20 –0.98 .046* 
 Private health insurance 33% 30% 36% 1.29 0.86 –1.93 0.211 
Risk factor profile           
 Current smoker 32% 35% 27% 0.69 0.46 –1.05 0.085 
 Prior hypertension 48% 42% 58% 1.91 1.13 –3.23 .015* 
 Prior diabetes 12% 12% 12% 1.02 0.54 –1.93 0.953 
Total cholesterol (mmol/l), mean 
(S.D) 
4.6 (1.2) 4.7 (1.2) 4.4(1.3) 0.79 0.66 –0.96 .019* 
 Prior coronary heart disease 29% 24% 38% 2.01 1.02 –3.94 .043* 
 Prior revascularization 24% 20% 30% 1.72 1.08 –2.74 .022* 
Hospitalization           
 Thrombolysis 24% 24% 26% 1.11 0.66 –1.88 0.699 
 Revascularization received 23% 24% 21% 0.8 0.49 –1.30 0.366 
 Cardiac arrest confirmed 16% 18% 11% 0.53 0.23 –1.18 0.118 
 Length of stay, mean (S.D) 8.6 (6.4) 7.8 (5.3) 9.8 (7.8) 1.05 1.03 –1.07 <.001*** 
 Left ventricular function (<40%) 13% 10% 19% 2.16 1.26 –3.72 .005** 
Co-morbidities           
 Modified Charlson Co-morbidity 
Index Score (median, interquar-
tile range) 
0 (0-1) 0 (0-0) 0 (0-1) 1.26 0.98 –1.63   0.072 
  
Baseline vulnerabilities           
 LTE-Q                                                                                               1.5 (1.7) 1.4 (1.5) 1.6 (1.9) 1.07 0.94 – 1.22 0.317 
 BJW-S 35.4 (6.2) 35.7 
(6.0) 
35.0 
(6.5) 
0.98 0.96 – 1.01 0.134 
 PES-AD 18.6(6.2) 18.6(5.7) 18.4 (7) 0.99 0.95 – 1.04 0.783 
 Type D (interaction)                                                                       120.9
(124.5) 
120.9
(119.1) 
120.7 
(133.5) 
1 1.00 – 1.00 0.985 
Trajectories           
No Depression 48% 52% 40% Reference 
Subthreshold Depression 37% 36% 38% 1.38 1.17-1.62 <.001*** 
Persistent Depression 15% 12% 21% 2.38 1.80-3.15 <.001*** 
*** p<0.001, ** p<0.01, * p<0.05 
  
  
Table 2: Multivariate logistic regression of risk factors on outcome 
Variables Odds Ratio C.I. (95%) P-Value 
    Age 1.02 1 - 1.04 0.038* 
Prior hypertension 1.24 0.65 - 2.36 0.521 
Total cholesterol 0.99 0.8 - 1.23 0.944 
Prior coronary heart disease 2.80 1.23 - 6.36 0.014* 
Prior revascularisation 1.19 0.56 - 2.53 0.659 
Length of stay 1.04 1.01 - 1.08 0.013* 
LVEF < 40% 1.72 0.81 - 3.67 0.16 
*** p<0.001, ** p<0.01, * p<0.05 
 
  
  
Table 3: Multinomial Path Model Excluding risk factors  
Any event Odds ratio C.I. (95%) P-Value 
Never depressed (reference)    
Subthreshold depression 1.38 1.17 - 1.62 <.001*** 
Persistent depression 2.38 1.8 - 3.15 <.001*** 
Never depressed (reference)    
Subthreshold depression    
Low reinforcement 1.21 1.02 - 1.43 .028* 
Non-belief in a just world 1.88 1.52 - 2.34 <.001 
Stressful life-event 1.74 1.26 - 2.4 .001** 
Type D personality (interaction) 1.61 0.98 - 2.64 .060 
Persistent Depression    
Low reinforcement 2.32 1.81 - 2.98 <.001*** 
Non-belief in a just world 2.27 1.64 - 3.14 <.001*** 
Stressful life-event 2.52 1.65 - 3.85 <.001*** 
Type D personality (interaction) 3.17 1.68 - 5.98 <.001*** 
Constant 0.16 0.08 - 0.29 <.001*** 
Baseline Depression    
Low reinforcement 1.44 1.15 - 1.8 .001** 
Non-belief in a just world 1.29 1.05 - 1.58 .016* 
Stressful life-event 2.04 1.28 - 3.26 .003** 
Type D personality 2.27 1.41 - 3.65 .001** 
Akaike Information Criteria 1224.14   
Bayesian Information Criteria 1267.31   
*** p<0.001, ** p<0.01, * p<0.05 
Depressive vulnerabilities reported in standardised values 
  
  
Table 4: Multinomial Path Model Including risk factors  
  Odds ratio C.I. (95%) P-Value 
Any event 
   Never depressed (reference) 
   Subthreshold depression 1.34 1.1 - 1.64 0.004** 
Persistent depression 2.73 1.89 - 3.94 <0.001*** 
    Age 1.03 1.01 - 1.05 0.001** 
Prior coronary heart disease 2.22 1.08 - 4.55 0.029* 
Length of stay 1.04 1.02 - 1.06 <0.001*** 
LVEF < 40% 1.73 0.91 - 3.29 0.095 
    Never depressed (reference) 
   
 
   Subthreshold depression 
   Low reinforcement 1.20 1 - 1.44 0.052 
Non-belief in a just world 1.92 1.52 - 2.42 <0.001*** 
Stressful life-event 1.73 1.26 - 2.38 0.001** 
Type D personality (interaction) 1.61 0.98 - 2.65 0.061 
Sex 1.24 0.5 - 3.1 0.64 
    Persistent Depression 
   Low reinforcement 2.31 1.78 - 2.99 0.052 
Non-belief in a just world 2.32 1.55 - 3.47 <0.001*** 
Stressful life-event 2.51 1.66 - 3.81 0.001** 
Type D personality 3.16 1.67 - 6 0.061 
Sex 1.27 0.26 - 6.19 0.64 
    Baseline Depression 
   Low reinforcement 1.44 1.15 - 1.8 0.001** 
Non-belief in a just world 1.29 1.05 - 1.58 0.016* 
Stressful life-event 2.04 1.28 - 3.26 0.003** 
Type D personality 2.27 1.41 - 3.65 0.001** 
Akaike Information Criteria 1137.80 
Bayesian Information Criteria 1180.57 
*** p<0.001, ** p<0.01, * p<0.05, Depressive vulnerabilities reported in standardised values,   
  
 
Figure 1a: Path diagram - theoretical specification, not adjusting for disease severity 
 
 
Figure 1b: Path diagram – theoretical specification, adjusting for disease severity 
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Table A1: Table of measures and when they were completed 
Hospitalisation 3 Months 6 Months 12 months 
HADS-D HADS-D HADS-D HADS-D 
BDI-FS BDI-FS BDI-FS BDI-FS 
BJW-S    
PES-SV    
LTE-Q    
DS14    
 
Beck Depression Inventory – Fast Screen (BDI-FS) 
Hospital Anxiety and Depression Scale (depression subscale) (HADS-D) 
List of threatening Experiences Questionnaire 
Belief in Just World-Self scale 
Pleasant Events Schedule – Alzheimer’s Disease (short version) 
Type D Scale – DS14 
 
  
  
Appendix B 
 
Fig B1 – Specified model (without demographic/disease indices) with co-efficients 
 
Fig B2 – Specified model (with demographic/disease indices) with co-efficients 
 
LOS= length of hospital stay 
  
  
Appendix C 
Table C1: Multinomial Path Models with 1 year all-cause morbidity/mortality as outcome 
  Excl. risk factors Incl. risk factors 
  Odds ratio C.I. (95%) P-Value Odds ratio C.I. (95%) P-Value 
Any event             
Never depressed (reference) 
 
  
   Subthreshold depression 1.39 0.92 - 2.11 0.117 1.35 0.89 - 2.03 0.157 
Persistent depression 2.50 1.59 - 3.91 <0.001 2.62 1.65 - 4.14 <0.001 
   
  
   Age - - - 1.02 1 - 1.03 0.097 
Prior coronary heart disease - - - 1.91 1.15 - 3.16 0.012 
Length of stay - - - 1.03 0.99 - 1.06 0.147 
LVEF < 40% - - - 1.47 0.84 - 2.58 0.178 
   
  
   Never depressed (reference) 
 
  
   
 
  
  
   Subthreshold depression 
  
  
   Low reinforcement 1.21 1.02 - 1.43 0.028 1.20 1 - 1.44 0.052 
Non-belief in a just world 1.88 1.52 - 2.34 <0.001 1.92 1.52 - 2.42 <0.001 
Stressful life-event 1.74 1.26 - 2.4 0.001 1.73 1.26 - 2.38 0.001 
Type D personality (interaction) 1.61 0.98 - 2.64 0.06 1.61 0.98 - 2.65 0.061 
Sex - - - 1.24 0.5 - 3.1 0.64 
   
  
   Persistent Depression 
  
  
   Low reinforcement 2.32 1.81 - 2.98 <0.001 2.31 1.78 - 2.99 <0.001 
Non-belief in a just world 2.27 1.64 - 3.14 <0.001 2.32 1.55 - 3.47 <0.001 
Stressful life-event 2.52 1.65 - 3.85 <0.001 2.51 1.66 - 3.81 <0.001 
Type D personality 3.17 1.68 - 5.98 <0.001 3.16 1.67 - 6 <0.001 
Sex - - - 1.27 0.26 - 6.19 0.765 
   
  
   Baseline Depression 
  
  
   Low reinforcement 1.44 1.15 - 1.8 0.001 1.44 1.15 - 1.8 0.001 
Non-belief in a just world 1.29 1.05 - 1.58 0.016 1.29 1.05 - 1.58 0.016 
Stressful life-event 2.04 1.28 - 3.26 0.003 2.04 1.28 - 3.26 0.003 
Type D personality 2.27 1.41 - 3.65 0.001 2.27 1.41 - 3.65 0.001 
AIC 1189.77 1124.22 
BIC 1232.93 1167.00 
  
  
Table C2: Multinomial Path Models with post 1 year morbidity/mortality as outcome 
  Excl. risk factors Incl. risk factors 
  Odds ratio C.I. (95%) P-Value Odds ratio C.I. (95%) P-Value 
Any event             
Never depressed (reference) 
 
  
   Subthreshold depression 1.12 0.37 - 3.38 0.837 1.14 0.35 - 3.75 0.83 
Persistent depression 1.65 0.87 - 3.14 0.126 2.17 0.84 - 5.61 0.108 
   
  
   Age - - - 1.07 1.04 - 1.1 <0.001 
Prior coronary heart disease - - - 1.49 0.65 - 3.45 0.349 
Length of stay - - - 1.05 0.99 - 1.1 0.094 
LVEF < 40% - - - 1.76 0.47 - 6.59 0.403 
   
  
   Never depressed (reference) 
 
  
   
 
  
  
   Subthreshold depression 
  
  
   Low reinforcement 1.21 1.02 - 1.43 0.028 1.20 1 - 1.44 0.052 
Non-belief in a just world 1.88 1.52 - 2.34 <0.001 1.92 1.52 - 2.42 <0.001 
Stressful life-event 1.74 1.26 - 2.4 0.001 1.73 1.26 - 2.38 0.001 
Type D personality (interaction) 1.61 0.98 - 2.64 0.06 1.61 0.98 - 2.65 0.061 
Sex - -  -  1.24 0.5 - 3.1 0.64 
   
  
   Persistent Depression 
  
  
   Low reinforcement 2.32 1.81 - 2.98 <0.001 2.31 1.78 - 2.99 <0.001 
Non-belief in a just world 2.27 1.64 - 3.14 <0.001 2.32 1.55 - 3.47 <0.001 
Stressful life-event 2.52 1.65 - 3.85 <0.001 2.51 1.66 - 3.81 <0.001 
Type D personality 3.17 1.68 - 5.98 <0.001 3.16 1.67 - 6 <0.001 
Sex -     1.27 0.26 - 6.19 0.765 
   
  
   Baseline Depression 
  
  
   Low reinforcement 1.44 1.15 - 1.8 0.001 1.44 1.15 - 1.8 0.001 
Non-belief in a just world 1.29 1.05 - 1.58 0.016 1.29 1.05 - 1.58 0.016 
Stressful life-event 2.04 1.28 - 3.26 0.003 2.04 1.28 - 3.26 0.003 
Type D personality 2.27 1.41 - 3.65 0.001 2.27 1.41 - 3.65 0.001 
AIC 958.78 908.68 
BIC 1001.95 951.45 
 
